Abbott SCSPENDING
Nevro SCSPENDING
Cyclosporiasis OutbreakPENDING
Dupixent CTCLNEW MDL
Boston Sci. SCSNEW MDL
AI Chatbot Harm
NEWMONITOR
Roundup
ACTIVE
AFFF
ACTIVE
Depo-Provera
QUIET
Talc
QUIET
PFAS
ACTIVE
NEC Formula
ACTIVE
Bard Hernia Mesh
QUIET
Covidien Hernia Mesh
ACTIVE
Camp Lejeune
ACTIVE
Paraquat
ACTIVE
Social Media
ACTIVE
PowerPort
ACTIVE
AngioDynamics Port
ACTIVE
EtO Sterilization
ACTIVE
Hair Relaxer
ACTIVE
Paragard
ACTIVE
Suboxone Teeth
ACTIVE
Uber Assault
ACTIVE
Lyft Assault
ACTIVE
Ozempic Gastroparesis
ACTIVE
Ozempic NAION
MONITOR
Church Abuse
ACTIVE
1,4-Dioxane
MONITOR
Hotel Trafficking
ACTIVE
Boy Scouts
QUIET
LDS Abuse
ACTIVE
Keytruda
ACTIVE
Tylenol
ACTIVE
Assembly of God
ACTIVE
Video Game Addiction
ACTIVE
CA Women's Prisons
ACTIVE
Zantac
ACTIVE
ByHeart Formula
MONITOR
Cartiva
MONITOR
Roblox
ACTIVE
Sports Betting
MONITOR
Baby Food Metals
QUIET
Benzene Litigation
ACTIVE
Discord Abuse
ACTIVE
Social Media Sextortion
MONITOR
UPF Litigation
MONITOR
47Tracked
28Active
3Pending
Navigation
Abbott SCSPENDING
Nevro SCSPENDING
Cyclosporiasis OutbreakPENDING
Dupixent CTCLNEW MDL
Boston Sci. SCSNEW MDL
AI Chatbot Harm
NEWMONITOR
Roundup
ACTIVE
AFFF
ACTIVE
Depo-Provera
QUIET
Talc
QUIET
PFAS
ACTIVE
NEC Formula
ACTIVE
Bard Hernia Mesh
QUIET
Covidien Hernia Mesh
ACTIVE
Camp Lejeune
ACTIVE
Paraquat
ACTIVE
Social Media
ACTIVE
PowerPort
ACTIVE
AngioDynamics Port
ACTIVE
EtO Sterilization
ACTIVE
Hair Relaxer
ACTIVE
Paragard
ACTIVE
Suboxone Teeth
ACTIVE
Uber Assault
ACTIVE
Lyft Assault
ACTIVE
Ozempic Gastroparesis
ACTIVE
Ozempic NAION
MONITOR
Church Abuse
ACTIVE
1,4-Dioxane
MONITOR
Hotel Trafficking
ACTIVE
Boy Scouts
QUIET
LDS Abuse
ACTIVE
Keytruda
ACTIVE
Tylenol
ACTIVE
Assembly of God
ACTIVE
Video Game Addiction
ACTIVE
CA Women's Prisons
ACTIVE
Zantac
ACTIVE
ByHeart Formula
MONITOR
Cartiva
MONITOR
Roblox
ACTIVE
Sports Betting
MONITOR
Baby Food Metals
QUIET
Benzene Litigation
ACTIVE
Discord Abuse
ACTIVE
Social Media Sextortion
MONITOR
UPF Litigation
MONITOR
47Tracked
28Active
3Pending
LexGenius Logo
LexGeniusYour Edge in Mass Litigation
PricingDaily DocketTrack litigations freeSign in
LexGenius

LexGenius

Your Edge in Mass Litigation

DisclaimerAcceptable UseTermsPrivacyCookie PolicySupport

© 2026 LexGenius. All rights reserved.

← All Briefs

Daily Intelligence Brief

Tuesday, August 11, 2026

Hair Relaxer Leads a Firm-Concentrated Docket

Hair-relaxer claims set the day’s pace as Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (3060) drew 17 filings, with Pulaski Kherkher PLLC filing seven and Wallace Miller four. Platform litigation held the next tier: Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047) added 10 cases, six from Levin Papantonio and one from Bossier & Associates PLLC. Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability (Gastroparesis) Litigation (3094) received nine complaints, five through Nigh Goldenberg Raso Vaughn PLLC and one through Hammers Law Firm LLC, extending the drug docket’s steady intake. PFAS and device claims each added seven cases, as Aqueous Film-Forming Foams Personal Injury Products Liability Litigation (2873) drew four filings from Keefe Law Firm LLC and one from The Law Firm of Hutchens Senter & Britton PA, while every new Covidien Hernia Mesh Products Liability Litigation (No. II) (3029) complaint came from Babin Law LLC. See the full filing feed and firm-level breakdowns here.

Ninth Circuit Keeps Social-Media Addiction Claims Alive

The Ninth Circuit on August 10 dismissed Meta’s and TikTok’s interlocutory appeals as premature, rejecting their bid to use a Section 230 defense to halt claims at the threshold in Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047). The ruling keeps more than 3,000 federal cases in the district court rather than allowing the defendants to convert an asserted liability defense into immediate appellate immunity. It does not decide whether any platform caused injury or owes damages, but it preserves the plaintiffs’ route to merits litigation. That procedural loss increases pressure on defendants to litigate the design, recommendation, notification and engagement evidence that their appeals sought to avoid.

California Social-Media Trial Moves to Jury Selection

Jury selection begins August 12 in California’s action against Meta, with opening statements scheduled for August 18, bringing Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047) to an immediate trial-stage test. The proceeding uses an advisory jury, leaving Judge Yvonne Gonzalez Rogers with ultimate authority over factual findings rather than delivering a conventional binding verdict. The schedule forces the parties to present their competing evidence on youth harm and platform design now, not after another round of threshold briefing. Its result will not resolve the full federal docket, but the evidence record and judicial findings will become an important measure of leverage as the broader litigation advances.

Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.